CIMAR’s Yoav Golan, MD, on the Recent Approval of Ceftolozane/Tazobactam for HABP/VABP by Levy CIMAR | Aug 17, 2025 | News
Phage Therapy to Prevent Cholera Infections and Possibly Those Caused by Other Deadly Bacteria by Levy CIMAR | Aug 16, 2025 | News
Joining Forces for Good: Tufts CIMAR and the Tufts Clinical and Translational Science Institute Encourage Multidisciplinary Collaboration. by Levy CIMAR | Aug 15, 2025 | News
The Death of Antibiotics: We’re Running Out of Effective Drugs to Fight Off an Army of Superbugs by Levy CIMAR | Aug 14, 2025 | News
Predicting TB’s Course: CIMAR’s Gillian Beamer Hopes to Unlock Why the Bacterium Affects Individuals Differently by Levy CIMAR | Aug 13, 2025 | News
